Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Covid can cause brain disorders two years after infection, study shows
    • Turkey surprises with interest rate cut as inflation soars
    • Fed officials signal restrictive rates may be needed ‘for some time’
    • Japan’s latest alcohol advice: please drink more
    • Taiwan tensions force multinationals to rethink China risk
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Mark Wahlberg-backed gym chain F45 goes from ab crunches to credit crunch
      • Average pay for PwC’s UK partners tops £1mn for first time
      • Jim Ratcliffe declares interest in buying Manchester United
      • China’s largest property group Country Garden warns of 70% plunge in profit
      • Britons expected to extend ‘pandemic trend’ of drinking more at home
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      • Cryptofinance
      Most Read
      • University student makes $110mn trading meme stock favourite Bed Bath & Beyond
      • Turkey surprises with interest rate cut as inflation soars
      • City of London regulators to face shake-up under Liz Truss
      • Taiwan tensions force multinationals to rethink China risk
      • Quant funds support market rally by ramping up bets on US stocks
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • It’s time for Europe to ask Norway to cut the price of gas
      • The truth that set Liz Cheney free
      • China’s chip breakthrough poses strategic dilemma
      • We should beware patronising the marginalised
      • The energy bills emergency has barely begun
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Business Book of the Year 2022 — the longlist
      • FT business books: what to read this month
      • Michelle O’Neill: ‘What I won’t allow is the unravelling of the Good Friday Agreement’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The village wedding caught in the Taliban’s battle for Kabul
      • Food writer Juana Pepa on her favourite things
      • When your childhood hero turns into a Trumpist
      • Chef Aktar Islam’s top places to eat in Toronto
      • It’s time to turn the page on your TV snobbery
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Your guide to a disrupted world

    Start a 4-week trial

    Imperial College London

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Sunday, 3 July, 2022
      Covid-19 vaccines
      Covid vaccines: how can immune imprinting help experts to rethink jabs?

      More than two years into the pandemic, people have acquired different levels of immunity through infections and shots

    • Sunday, 29 May, 2022
      Climate change
      Imperial College London to set up centre to help decarbonise aviation

      Institute established with £25mn donation will examine all aspects of sector, from fuel to airport infrastructure

    • Thursday, 7 April, 2022
      Scientific research
      Imperial College reinforces European links with French partnership

      Threat of UK exclusion from EU research may prompt other universities to establish bilateral links

    • Sunday, 13 February, 2022
      MBA
      How to make your MBA application stand out

      Admissions directors offer practical tips on what to do — and what to avoid

    • Wednesday, 2 February, 2022
      Coronavirus treatment
      Covid sufferers become infectious quicker than first thought, study shows

      Findings follow the first trial in which volunteers were deliberately infected with virus

    • Wednesday, 22 December, 2021
      Coronavirus pandemic
      UK reports record 106,000 coronavirus cases

      Boris Johnson coming under pressure to clarify whether England faces post-Christmas restrictions

    • Friday, 17 December, 2021
      Coronavirus pandemic
      ‘No evidence’ Omicron less severe than Delta, say UK researchers

      Weekend emergency meeting of ministers set to look at ‘pretty bleak’ data after third record day of new cases

    • Thursday, 28 October, 2021
      Covid-19 vaccines
      Vaccines reduce risk of Delta infection in the home by about a third

      UK scientists warn that unvaccinated people cannot rely on close contacts who have been jabbed to protect them

    • Tuesday, 6 July, 2021
      Coronavirus pandemic
      England’s Covid experiment: can jabs counter fast-rising infections?

      Ministers are banking on vaccines’ ‘protective wall’ to enable the lifting of restrictions

    • Wednesday, 23 June, 2021
      A psychedelic guide to wellbeing
      Advances in psychedelics could change investors’ minds

      Potential treatments for addiction and mental illnesses are gathering pace

    • Thursday, 17 June, 2021
      Ara Darzi
      Antibody screening could transform Covid-19 vaccine distribution

      Testing may enable wealthy nations to donate their booster shots to help the poorest countries

    • Tuesday, 2 March, 2021
      A psychedelic guide to wellbeing
      Microdosing study shows placebo effect of taking psychedelics

      UK research into LSD consumption reveals expectation of improved wellbeing drives transformation

    • Wednesday, 17 February, 2021
      Medical science
      World’s first trial of deliberate coronavirus infection is approved

      Challenge study in London will provide platform for future vaccine development

    • Thursday, 28 January, 2021
      Coronavirus pandemic
      England lockdown starts to suppress Covid-19, study suggests

      Imperial College London data show rate of infection close to stable or falling slightly

    • Tuesday, 26 January, 2021
      Covid-19 vaccines
      Imperial College to target coronavirus mutations

      London university ditches plans for efficacy trial to focus on developing next-generation jabs

    • Tuesday, 5 January, 2021
      Coronavirus pandemic
      More infectious Covid variant forces review of UK workplace guidance

      B.1.1.7 virus is estimated to be between 60 and 70 per cent more transmissible

    • Friday, 1 January, 2021
      Coronavirus pandemic
      Covid variant spread rapidly in England even during lockdown, study finds

      Government caves in to demands and closes all London primary schools in latest U-turn

    • Thursday, 19 November, 2020
      Coronavirus treatment
      Arthritis drug offers hope for severely ill Covid patients

      Scientists optimistic it can be added to armoury of treatments for most critically sick

    • Tuesday, 27 October, 2020
      Coronavirus treatment
      Covid-19 herd immunity theory dealt blow by UK research

      Testing of more than 350,000 people shows that antibodies fade within few months

    • Tuesday, 20 October, 2020
      Coronavirus treatment
      Volunteers to be infected with coronavirus in world’s first ‘human challenge’ trials

      Up to 90 fit people aged 18-30 in London will be deliberately infected with virus in effort to accelerate vaccine development

    • Thursday, 1 October, 2020
      Coronavirus pandemic
      Growth in coronavirus infections is slowing in England, survey suggests

      Study signals that curbs are having an effect as government announces further restrictions in north

    • Thursday, 20 August, 2020
      The companies coping with Covid-19
      Treasury enters realm of venture investing with AI start-up Monolith

      East London-based company secures emergency funding in just 48 hours after pandemic led to orders drying up

    • Wednesday, 10 June, 2020
      Coronavirus pandemic
      Earlier lockdown could have halved UK deaths, says PM’s ex-adviser

      Neil Ferguson of Imperial College says imposing coronavirus restrictions a week before would have drastically reduced toll

    • Thursday, 28 May, 2020
      FT AlphavilleJemima Kelly
      Is the “science” behind the lockdown any good?

      (Spoiler: it’s a lot better than nothing. But it should not be followed at the expense of all else.)

    • Saturday, 23 May, 2020
      Coronavirus pandemic
      ‘Politicised nature’ of lockdown debate delays Imperial report

      Neil Ferguson’s team has sent modelling findings to government but not released them to the public

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      • Cryptofinance
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Community
      • FT Live
      • FT Forums
      • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In